Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug development
Biotech
Hansoh heralds China’s move from ‘follower’ to ‘frontrunner’
Hansoh gave a bullish assessment of China’s biopharma role, arguing that it is “fully transitioning from the ‘follower’ to the ‘frontrunner’ phase.”
Nick Paul Taylor
Aug 26, 2026 9:33am
Why a congressman says China is 'beating us on our ground game'
Aug 25, 2026 9:45am
Eli Lilly takes top spot on new biopharma productivity ranking
Jul 28, 2026 1:00pm
How India can build on its budding innovative R&D moment: report
Jul 23, 2026 5:00am
HHS unveils plan to speed up ph. 1 trials by 6 to 12 months
Jun 22, 2026 12:10pm
Altaris scoops up AI drug development outfit for $375M
Jun 16, 2026 12:13pm
